Curcumin as a potential therapeutic option for NAFLD and other metabolic diseases: need for establishing the underlying mechanism(s) of action Shobha Ghosh Editorial 19 March 2019 Pages: 245 - 247
Liver damage related to immune checkpoint inhibitors Naoshi NishidaMasatoshi Kudo Review Article 03 January 2019 Pages: 248 - 252
Correction to: End-points for drug treatment in NASH Leon A. Adams Correction 09 May 2019 Pages: 259 - 259
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results Xieer LiangZhiliang GaoJinlin Hou Original Article Open access 11 April 2019 Pages: 260 - 269
Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patients Benjamin EmmanuelSamer S. El-KamaryShyam Kottilil Original Article 05 March 2019 Pages: 270 - 276
C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3 Hang LiBo ZhangXianfeng Gan Original Article 08 May 2019 Pages: 277 - 292
Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study Tatsuya IdeHironori KogaTakuji Torimura Original Article 28 February 2019 Pages: 293 - 301
The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials Zhongcao WeiNa LiuJinhai Wang Original Article 16 November 2018 Pages: 302 - 313
Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka Madunil Anuk NiriellaA. KasturiratneH. J. de Silva Original Article 11 December 2018 Pages: 314 - 322
Bi-lobar liver biopsy via EUS enhances the assessment of disease severity in patients with non-alcoholic steatohepatitis Sandeep KhuranaWaseem ButtDavid L. Diehl Original Article 16 April 2019 Pages: 323 - 329
AARC-ACLF score: best predictor of outcome in children and adolescents with decompensated Wilson disease Seema AlamBikrant Bihari LalGuresh Kumar Original Article 19 March 2019 Pages: 330 - 338
A proposed pathologic sub-classification of drug-induced liver injury Tailing WangXinyan ZhaoJidong Jia Original Article 11 April 2019 Pages: 339 - 351